Malik H, Hudaib M, Rehman A. Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment. J Pak Med Assoc [Internet]. 2024 Sep. 21 [cited 2026 Apr. 20];74(10):1912-3. Available from: https://mail.jpma.org.pk/index.php/public_html/article/view/20428